Couverture de A New Deal for Cancer

A New Deal for Cancer

Lessons from a 50 Year War

Aperçu

30 jours d'essai gratuit à Audible Standard

Essayer Standard gratuitement
Choisissez 1 livre audio par mois dans l'ensemble de notre catalogue.
Écoutez les livres audio que vous avez choisis pendant toute la durée de votre abonnement.
Accédez à volonté à des podcasts incontournables.
Gratuit avec l'offre d'essai, ensuite 2,99 €/mois. Possibilité de résilier l'abonnement chaque mois.

A New Deal for Cancer

De : Abbe R. Gluck - editor, Charles S Fuchs - editor
Lu par : Brittany Pressley, Graham Halstead
Essayer Standard gratuitement

Renouvellement automatique à 2,99 € mois après 30 jours. Annulation possible chaque mois.

Acheter pour 22,11 €

Acheter pour 22,11 €

À propos de ce contenu audio

An unprecedented constellation of experts—leading cancer doctors, policymakers, cutting-edge researchers, national advocates, and more—explore the legacy and the shortcomings from the fifty-year war on cancer and look ahead to the future.

The longest war in the modern era, longer than the Cold War, has been the war on cancer. Cancer is a complex, evasive enemy, and there was no quick victory in the fight against it. But the battle has been a monumental test of medical and scientific research and fundraising acumen, as well as a moral and ethical challenge to the entire system of medicine. In A New Deal for Cancer, some of today’s leading thinkers, activists, and medical visionaries describe the many successes in the long war and the ways in which our deeper failings as a society have held us back from a more complete success.

Together they present an unrivaled and nearly complete map of the battlefield across dimensions of science, government, equity, business, the patient provider experience, and more, documenting our emerging understanding of cancer’s many unique dimensions and offering bold new plans to enable the American health care system to deliver progress and hope to all patients.

Amériques Médecine et secteur des soins de santé États-Unis
Aucun commentaire pour le moment